| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/2009 | EP2052599A1 Early-maturing transformed plant |
| 04/29/2009 | EP2052253A2 Immunogenic compounds and protein mimics |
| 04/29/2009 | EP2052082A2 Chimeric newcastle disease virus vlps |
| 04/29/2009 | EP2052011A1 Targeted polylysine dendrimer therapeutic agent |
| 04/29/2009 | EP2051996A1 Method for engineering t-cell receptors |
| 04/29/2009 | EP2051995A1 Selective glucagon-like-peptide-2 (glp-2) analogues |
| 04/29/2009 | EP2051994A1 Method of screening for compounds with anti-amyloid properties |
| 04/29/2009 | EP2051993A2 Amigo-2 inhibitors for treating, diagnosing or detecting cancer |
| 04/29/2009 | EP2051988A2 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 04/29/2009 | EP2051965A2 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 04/29/2009 | EP2051734A2 Agents for blood-brain barrier delivery |
| 04/29/2009 | EP1943276A4 Crystal structure of human urokinase plasminogen activator amino terminal fragment bound to its receptor |
| 04/29/2009 | EP1771569A4 Methods and compositions for modulating flowering and maturity in plants |
| 04/29/2009 | EP1758935B1 High affinity telomerase t cell receptors |
| 04/29/2009 | EP1673630A4 Mn/ca ix and cancer prognosis |
| 04/29/2009 | EP1461357B1 Novel hev antigenic peptide and methods |
| 04/29/2009 | EP1381272B1 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors |
| 04/29/2009 | EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 04/29/2009 | EP1265927B1 Crystal |
| 04/29/2009 | EP1257582B1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1212439B1 Plants having altered amino acid contents and method for the production thereof |
| 04/29/2009 | EP1051494B1 Methods and reagents for decreasing allergic reactions |
| 04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/29/2009 | CN101421416A Method for designing polypeptides for the nanofabrication of thin films, coatings and microcapsules by electrostatic layer-by-layer self assembly |
| 04/29/2009 | CN101421411A Taurine transporter gene |
| 04/29/2009 | CN101421405A Proteins associated with abiotic stress response and homologs |
| 04/29/2009 | CN101421403A Compositions and methods for humanization and optimization of n-glycans in plants |
| 04/29/2009 | CN101421306A Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 04/29/2009 | CN101421300A Novel sodium channel |
| 04/29/2009 | CN101421299A Peptide vaccine for inducing production of anti-amyloid- -peptide antibody |
| 04/29/2009 | CN101421298A Novel composition and methods for the treatment of immune related diseases |
| 04/29/2009 | CN101421297A Peptides that block the binding of igg to fcrn |
| 04/29/2009 | CN101421296A Hypoallergenic chimeric proteins belonging to the lipid transfer family of Parietaria judaica for use in the treatment of allergies |
| 04/29/2009 | CN101421295A Genes for enhancing nitrogen utilization efficiency in crop plants |
| 04/29/2009 | CN101421294A Recombinant newcastle disease virus expressing H5 hemagglutinin of avian influenza virus |
| 04/29/2009 | CN101420983A Methods and compositions comprising supramolecular constructs |
| 04/29/2009 | CN101420977A NOGO receptor antagonists |
| 04/29/2009 | CN101418328A Method for producing fish scale collagen protein |
| 04/29/2009 | CN101418304A Method for preparing soluble E2 antigen for detecting swine fever virus serum antibody |
| 04/29/2009 | CN101418303A Method for preparing swine fever recombinant subunit vaccine |
| 04/29/2009 | CN101418301A Upland cotton disease-resistant gene and use thereof |
| 04/29/2009 | CN101418300A Gene for improving plant salt tolerance and drought resistance and use thereof |
| 04/29/2009 | CN101418295A Biosensor and use thereof |
| 04/29/2009 | CN101418275A Streptococcus suis type 2 immune protective antigen |
| 04/29/2009 | CN101418047A Antigen-antibody compound crystal and preparation method thereof and antigen epitope |
| 04/29/2009 | CN101418042A Separation and purification of recombinant human blood vessel endothelia cell growth factor, chemical labeling in vitro and use thereof |
| 04/29/2009 | CN101418041A Transfer factor of anti-swine fever |
| 04/29/2009 | CN101418040A Plant jasmonate acid signal transduction regulatory protein and coding gene and use thereof |
| 04/29/2009 | CN100482801C Promoters for expressing genes in fungal cell |
| 04/29/2009 | CN100482796C Expression of recombinant ox growth hormone in pichia pastoris |
| 04/29/2009 | CN100482795C IREN protein, its preparation and use |
| 04/29/2009 | CN100482793C Characterization of the gsk-3 beta protein and methods of use thereof |
| 04/29/2009 | CN100482687C Human 5-HT7 receptor promoter sequence |
| 04/29/2009 | CN100482686C Treatment for diabetes |
| 04/29/2009 | CN100482685C Tolerogenic peptides from myelin basic protein |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482682C Novel melanocortin receptor agonists |
| 04/29/2009 | CN100482679C Process of purification of hCG and recombinant hCG purified by that method |
| 04/29/2009 | CN100482674C Reduction of dermal scarring |
| 04/29/2009 | CN100482283C Novel chimeric CD154 |
| 04/28/2009 | US7525028 Soybean variety 4274171 |
| 04/28/2009 | US7525014 Transgenic magnaporthe resistant rice; tissue engineering; horticulture |
| 04/28/2009 | US7525011 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 04/28/2009 | US7524947 Recombinant viral-based malaria vaccines |
| 04/28/2009 | US7524944 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 04/28/2009 | US7524943 Using vector transformation to insert plasmid which express antisense sequences which reduce proanthocyanidin (PA) in plant seed coats; enhancing feed quality and digestibility |
| 04/28/2009 | US7524941 Methods for the preparation of chemically misaminoacylated tRNA via protective groups |
| 04/28/2009 | US7524940 OB protein compositions and methods |
| 04/28/2009 | US7524937 Reducing body weight or food intake ; binding to antibody |
| 04/28/2009 | US7524935 Sequences characteristic of hypoxia-regulated gene transcription |
| 04/28/2009 | US7524934 Human brain carboxypeptidase B antibodies |
| 04/28/2009 | US7524933 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength |
| 04/28/2009 | US7524932 Lactalbumin production process |
| 04/28/2009 | US7524931 Full-length interferon gamma polypeptide variants |
| 04/28/2009 | US7524930 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 04/28/2009 | US7524929 polypeptides comprising an amino acid sequence of a photocatalytic unit of a photosynthetic microorganism, capable of maintaining photocatalytic activity when attached to solid surfaces of electrooptic devices |
| 04/28/2009 | US7524928 IFN receptor 1 binding proteins |
| 04/28/2009 | US7524927 Compositions, method and kits relating to deletion mutations of immunodeficiency virus gp120 hypervariable regions |
| 04/28/2009 | US7524875 Polyether with glycerol backbone; capable of being labeled |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524820 Administering one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides, to inhibit neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 04/28/2009 | US7524818 Pure polypeptide of sequence Tyr-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu; controlled release and liposome formulations |
| 04/28/2009 | US7524817 Osteogenic protein/bone morphogenetic proteins of eukaryotic origin |
| 04/28/2009 | US7524816 Peptides and supported peptides for treating skin diseases |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524814 Lactoferrin compositions and methods of wound treatment |
| 04/28/2009 | US7524813 Selectively conjugated peptides and methods of making the same |
| 04/28/2009 | US7524812 A Omega-conopeptide, and the anitoxidant methionine, and either clonidine or baclofen; ziconotide retains its potency and is physically and chemically compatible with the analgesic; for intrathecal administration |
| 04/28/2009 | US7524810 Modified Cry34 proteins |
| 04/28/2009 | US7524674 Triple or double fusion vector harboring a Positron Emission Tomographic (PET), a bioluminescence and a fluorescence reporter gene that is imageable in living cells using a fluorescence microscope, a charge couple camera |
| 04/28/2009 | US7524669 Comprising a disrupted ACR3 gene; treating waste water containing heavy metal ion such as As; pollution control |
| 04/28/2009 | US7524663 immunogens and epitopes used for treatment of autoimmune diseases; catalytic antibodies |
| 04/28/2009 | US7524660 Utilization of fructose in microbial production strains |
| 04/28/2009 | US7524657 Alleles of the sigA gene from coryneform bacteria |
| 04/28/2009 | US7524656 Ability to produce L-glutamic acid, arginine or lysine is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 04/28/2009 | US7524650 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | US7524647 Biosynthesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases |
| 04/28/2009 | US7524644 Expression vector comprising enzymatic polypeptide for use in prevention and treatment of blood clots; thrombolytic agents |